These medications cross the blood-brain barrier readily, causing drowsiness, cognitive impairment, and potential falls riskparticularly concerning for older adults with hypertension who may already be at increased cardiovascular risk
Years before semaglutide became a blockbuster drug for Novo Nordisk, the Danish pharma giant had the chance to maintain its patent in Canada but didn't pay a small fee to do so, according to a recent report in Science
If you find yourself struggling with side effects after increasing your dose, drop down to the dose below for another 4 weeks
By January 2027, payers must offer FHIR-based PA APIs for electronic submission through EHR systems
There is currently no evidence that retatrutide selectively preserves muscle mass in the context of aggressive caloric restriction or high-volume training
Oral contraceptives depend on consistent absorption in the small intestine to maintain therapeutic hormone levels